GENESIS MAGMA RACING TEAM AND DRIVERS TAKE VALUABLE LESSONS FROM IMOLA ADVERSITY
Genesis Magma Racing Trajectory programme drivers Jamie Chadwick, Mathys Jaubert and Dani…
Genesis AI Emerges From Stealth with $105M to Build Universal Robotics Foundation Model and Horizontal Platform for General-Purpose Physical AI
With funding co-led by Eclipse and Khosla Ventures, Genesis will develop breakthrough…
33 year old driver from Tripura treated with Eastern India’s first-ever Bachmann’s Bundle Pacing
KOLKATA, India, June 27, 2025 /PRNewswire/ -- In a landmark achievement that…
Asteroid Day Gains Momentum with U.S. Recognition from Flagstaff, Coconino County, U.S. Senate, and Vera C. Rubin Observatory Data Release
LUXEMBOURG, June 25, 2025 /PRNewswire/ -- The Asteroid Foundation, working in collaboration…
From Insight to Impact: BingX AI Matures into a Full-Service Crypto Trading Assistant
PANAMA CITY, June 24, 2025 /PRNewswire/ -- BingX, a leading cryptocurrency exchange…
From Vision to Action: CIIE Empowers Global Development Through Inclusive Cooperation
SHANGHAI, June 25, 2025 /PRNewswire/ -- Amid growing global uncertainty and anti-globalization…
WISeKeys Subsidiaries WISeSat and SEALSQ Launch New Satellite with SpaceX, Enabling the First-Ever DePIN from Space and Advancing Quantum-Safe Space Communications
June 23, 2025 18:36 ET | Source: Wisekey International Holding Ltd. Courtesy…
WISeSat.Space and SEALSQ Launch New Satellite with SpaceX, Enabling the First-Ever DePIN from Space, and Advancing Quantum-Safe Space Communications
June 23, 2025 18:30 ET | Source: SEALSQ Geneva, Switzerland, June 23,…
Scilex Holding Company Announces Deferral of Record Date for its Previously Announced Dividend of Preferred Stock Exchangeable for up to 10% of Scilexs Ownership Interest in Semnur Pharmaceuticals, Inc., its Wholly Owned Subsidiary from May 2, 2025 to a f
June 23, 2025 16:50 ET | Source: Scilex Holding Company PALO ALTO,…
Novo Nordisk A/S: Mim8 prophylaxis treatment shown to be well-tolerated when switching from emicizumab in people with haemophilia A in new phase 3 data presented at the ISTH 2025 Congress
New FRONTIER5 data show that a direct switch to investigational Mim8 (denecimig)…
